On Tuesday, Agios Pharmaceuticals Inc (NASDAQ: AGIO) was 5.99% up from the session before settling in for the closing price of $41.38. A 52-week range for AGIO has been $23.42 – $62.58.
When this article was written, the company’s average yearly earnings per share was at -160.31%. With a float of $55.06 million, this company’s outstanding shares have now reached $58.28 million.
Agios Pharmaceuticals Inc (AGIO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agios Pharmaceuticals Inc stocks. The insider ownership of Agios Pharmaceuticals Inc is 5.58%, while institutional ownership is 106.07%. The most recent insider transaction that took place on Oct 30 ’25, was worth 8,762. In this transaction Chief Medical Officer of this company sold 200 shares at a rate of $43.81, taking the stock ownership to the 61,727 shares. Before that another transaction happened on Oct 30 ’25, when Company’s Officer proposed sale 200 for $43.81, making the entire transaction worth $8,762.
Agios Pharmaceuticals Inc (AGIO) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.74 earnings per share (EPS) during the time that was less than consensus figure (set at -1.63) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.93 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -160.31% per share during the next fiscal year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
You can see what Agios Pharmaceuticals Inc (AGIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 57.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.96, a number that is poised to hit -1.94 in the next quarter and is forecasted to reach -7.13 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Compared to the last year’s volume of 0.69 million, its volume of 0.45 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 59.04%.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 97.77%, which indicates a significant increase from 92.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.81 in the past 14 days, which was higher than the 1.67 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.94, while its 200-day Moving Average is $34.94. Nevertheless, the first resistance level for the watch stands at $44.79 in the near term. At $45.72, the stock is likely to face the second major resistance level. The third major resistance level sits at $47.53. If the price goes on to break the first support level at $42.04, it is likely to go to the next support level at $40.23. Now, if the price goes above the second support level, the third support stands at $39.30.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
There are 58,314K outstanding shares of the company, which has a market capitalization of 2.56 billion. As of now, sales total 36,500 K while income totals 673,730 K. Its latest quarter income was 12,880 K while its last quarter net income were -103,430 K.
